Production (Stage)
Creative Medical Technology Holdings, Inc.
CELZ
$2.13
-$0.05-2.29%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -15.42% | -3.91% | 45.87% | 38.71% | 47.45% |
| Total Depreciation and Amortization | 10.91% | 16.93% | 23.26% | 16.41% | 9.57% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1,051.85% | 1,262.96% | -92.66% | -92.66% | -92.64% |
| Change in Net Operating Assets | -154.35% | 101.59% | -53.08% | 181.15% | 160.05% |
| Cash from Operations | -17.96% | 33.96% | 46.04% | 40.11% | 49.48% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -104.06% | 83.45% | 384.92% | 198.82% | 197.75% |
| Cash from Investing | -104.06% | 83.45% | 384.92% | 198.82% | 197.75% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 71.11% | 35.42% | -32.53% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1,482.53% | 636.75% | -32.48% | -- | -102.29% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -156.37% | 150.96% | 114.07% | 118.45% | -237.77% |